Medios AG: Accelerated Growth in the First Half of the Year Rewarded With Share Price Increases!
Reading Time: 2 minutes
Medios AG is a leading provider of specialty pharmaceuticals in Europe. On August 13, the company released its half-year report. According to it, revenue increased by 9.3% to €991.7 million compared to the same period last year. Adjusted EBITDA rose disproportionately by 48.8% to €46.3 million, with a remarkable organic growth of 12.3%. Net income after taxes also nearly doubled to €12.7 million. All three business segments—pharmaceutical supply, personalized therapies, and international business—contributed significantly to this success....
Read this article now with a free account.
Your benefits:
- Every month, you can read 5 articles from the premium section for free.
- Monthly 2 trial issues of the Trader newspaper for free.
- Create a personal watchlist with an overview of news about your stock.
